Holding website  

ABOUT US

APR Applied Pharma Research s.a. (APR), as part of the Relief Group of companies, is a Swiss company dedicated to providing patients suffering from rare diseases with innovative treatments that make a real difference in their life.

Our focus, as a Swiss biopharma company is the identification, development and commercialization of best-in-class, patent protected products in selected rare and ultra-rare disease areas.

Optimizing a product's therapeutic potential by developing and applying advanced patented pharma technologies as well as through proprietary delivery systems or novel dosage forms is our way to add value to the rare diseases field.

Our Services

Collaborations & Partnering

APR Applied Pharma Research

Has a proven track record in developing branded and patented products worldwide.
Counts on a balanced mix of marketed, revenue-generating products and a compelling pipeline
of innovative products in rare indications
at different stages of development, with main focus
on rare recessive metabolic diseases, rare dermatological diseases and ocular diseases.
Offers late-stage licensing opportunities for internally developed products.
Provides a complete and vertically integrated range of contract R&D services - from formulation
to regulatory support on an international basis.


Pharmaceutical Research and development
Our Network Worldwide

The company is headquartered in Switzerland. With our extensive network of commercial partners, APR's products are distributed in more than 70 countries worldwide, whereas the Company distributes and markets directly with its own sales and marketing organization a selection of our products in rare diseases field in selected countries of Europe.

Collaborations
& Partnering

Our Services

APR 2015 all rights reserved | About us | APR Products | Our services | News & Events | Contact | Privacy policy | Cookie policy | Sitemap